Emyria Ltd's new board appointee puts it one step closer to FDA registration
“Emyria is uniquely placed to accelerate treatment development as one of only a few companies operating a network of clinical services,...
Stay updated with breaking news from Acceleron Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
“Emyria is uniquely placed to accelerate treatment development as one of only a few companies operating a network of clinical services,...
Sydney, Nov. 30, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered...
MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors SAN DIEGO, November 23, 2021 - MEI Pharma, Inc. , a late-stage pharmaceutical... | November 23, 2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced the successful completion of the acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN). “This is an important and strategic opportunity for our company to continue growing our cardiovascular portfolio and pipeline, that builds on ...
MEI Pharma Appoints Biotechnology Executive Sujay Kango to its Board of Directors - read this article along with other careers information, tips and advice on BioSpace